Evidence map›Paper›PMID 39480081›Full record

ArticlemSphere2024

Adaptation to zinc restriction in

M Melet, S Blanchet, P Barbarin, E A Maunders, S L Neville, V Rong, L Mereghetti, C A McDevitt, A Hiron

Abstract read
In one paragraph

Article in mSphere, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

M MeletISP, Université de Tours, Tours, France.
S BlanchetISP, Université de Tours, Tours, France.
P BarbarinISP, Université de Tours, Tours, France.
E A MaundersDepartment of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Australia.
S L NevilleDepartment of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Australia.
V RongISP, Université de Tours, Tours, France.
L MereghettiISP, Université de Tours, Tours, France.
C A McDevittDepartment of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Australia.
A HironISP, Université de Tours, Tours, France.ORCID 0000-0001-7894-5985

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Zinc (Zn) is an essential cofactor for numerous bacterial proteins and altering Zn availability is an important component of host innate immunity. During infection, adaptation to both Zn deprivation and excess is critical for pathogenic bacteria development. To understand the adaptive responses to Zn availability of IMPORTANCE:

Indexed as

Bacterial ProteinsGene Expression Regulation, BacterialRibosomal ProteinsStreptococcus agalactiaeZincAdaptation, PhysiologicalATP-Binding Cassette TransportersGene Expression ProfilingHomeostasisHumansRegulonStreptococcal InfectionsATP-Binding Cassette TransportersBacterial ProteinsRibosomal ProteinsZincduplicated ribosomal proteinsgene regulationmetal ABC-transporterStreptococcus agalactiaezinc homeostasis

Identifiers

PMID39480081
PMCPMC11580457

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.